Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Ascletis Pharmaceuticals Co., Ltd.

Clinical trials sponsored by Ascletis Pharmaceuticals Co., Ltd., explained in plain language.

Completed 2
Sort by
  • New pill shows promise for Hard-to-Treat cancers

    Disease control Completed

    This early-stage trial tested a new oral drug called ASC61 in 18 adults with advanced solid tumors that had stopped responding to standard treatments or had no standard options. The goal was to check the drug's safety, find the right dose, and see if it could shrink tumors. ASC61…

    Phase: PHASE1 • Sponsor: Ascletis Pharmaceuticals Co., Ltd. • Aim: Disease control

    Last updated May 01, 2026 15:57 UTC

  • New acne pill passes Long-Term safety check in phase 3 trial

    Symptom relief Completed

    This study looked at the long-term safety of a daily pill called ASC40 (Denifanstat) for people with moderate to severe acne. About 240 people who had already finished a 12-week study took the pill for up to 40 weeks. Researchers tracked side effects and checked blood tests to se…

    Phase: PHASE3 • Sponsor: Ascletis Pharmaceuticals Co., Ltd. • Aim: Symptom relief

    Last updated May 01, 2026 15:59 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space